key: cord-0864661-064lkeen authors: Sienaert, Pascal; Lambrichts, Simon; Popleu, Leen; Van Gerven, Elke; Buggenhout, Satya; Bouckaert, Filip title: Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait date: 2020-04-22 journal: Am J Geriatr Psychiatry DOI: 10.1016/j.jagp.2020.04.013 sha: f9984cd255bf5b0f95061d99c13ef69f3e843dc6 doc_id: 864661 cord_uid: 064lkeen nan T he rapidly evolving pandemic of coronavirus disease 2019 (COVID-19) is a major challenge for health services and drastic measures have been taken to contain this global crisis. Anticipating a shortage of health-care providers, in particular anesthesiologists, hospitals around the world did not hesitate to close down their electroconvulsive therapy (ECT)-units. In Flanders, a region in Belgium with 6,596,000 inhabitants, 70% of the ECT-units stopped treatments from the start of the pandemic. The remaining have put treatments for older patients residing in nursing homes on hold. Reasons cited are unavailability of anesthesiologists rescheduled to work in intensive care units, shortage of muscle relaxants needed for mechanical ventilation of COVID-patients, and fear of virus transmission through bag-mask-ventilation during the ECT-procedure. Another reason for closing down the ECT-service is that ECT is considered an elective intervention, and that, moreover, "psychiatry can wait." It is not unusual for patients with a psychiatric disorder to experience poor access to health care compared with people without a psychiatric disorder. 1 But, as eloquently argued by Espinoza et al., 2 in this COVID-era, ''ECT is a lifesaving gem," an often essential medical procedure that should not be discarded as an elective intervention. In this challenging time, the need to deliver care for older adults experiencing serious mental illness is higher than ever. ECT not only yields high remission rates in older patients, 3 it is often life-saving in patients refusing food and fluid intake, or those with psychotic depression, catatonia, and suicidality. 4 In considering the implications of COVID-19 for ECT, it is important for psychiatrists to carefully review the treatment needs in consultation with patients and their families. If ECT is stopped, the 6-month relapse rate with continuation pharmacotherapy will mount up to 37%. 5 Relapse rates after discontinuing an ongoing maintenance-ECT (M-ECT) are similar. 6, 7 Moreover, it is of note that, apart from the burden caused by a depressive relapse, in this particular pandemic context, a depressive relapse might make older patients more vulnerable to infectious diseases. It is known that depression is associated with immunological impairments, especially in older adults, 8 and that in stressful situations, mortality from viral respiratory infections is higher. 9 Therefore, when M-ECT is withheld, or the intertreatment interval is lengthened, a close follow-up is of utmost importance. A protocol of using rescue ECT-sessions based on monitoring of psychiatric symptoms through televisits, 10 using validated rating scales, and providing ECT only in case of early signs of relapse, 11 should be considered standard clinical care in these exceptional times. This practice was shown to be feasible in a large trial on flexible M-ECT in older patients. 12 In an attempt to contain the epidemic, the Belgian government issued on April 3th 2020 all day hospitalizations for persons over 65 years of age to be closed temporarily. As a consequence, M-ECT for outpatients was kept to a strict minimum. More specifically, older patients residing in nursing homes could not be treated on an outpatient basis, in order to protect their fellow-patients from infection. On a weekly basis, assessments were performed via telephone consultations with patients and/or care-providers. If possible, a standardized rating scale was used. Furthermore, cases were discussed on a weekly (video) ECT-team meeting. If signs of relapse were emerging, or in case of increasing suicidality, patients were readmitted to apply rescue ECT starting with ECT twice a week. Readmission was organized in a 7-day quarantineregime, with close follow-up of clinical signs and screening for COVID through polymerase chain reaction (PCR) testing. To safely administer ECT, protecting staff and patients from exposure to respiratory droplets, our unit, situated in a tertiary psychiatric hospital, adopted a number of additional safety measures. A nasopharyngeal swab for PCR-testing was performed the day before ECT. Hospitalized patients were monitored daily for symptoms of fever, coughing and dyspnea; PCR-testing was repeated once a week. Outpatients had PCR-testing the day before a treatment-session. Patients with a positive PCR-test were treated at the end of the program to prevent contamination of the treatment room and to enable rigorous cleaning afterwards. The treatment room was adequately ventilated ensuring ventilation with air flow of 5 air changes per hour, 13 and all medical devices and high touch surfaces were disinfected with a chlorine solution after every treatment. After treating a patient with a positive PCR-test the entire treatment room, including the floor, was cleaned with a chlorine solution. The number of persons present in the treatment room was kept to the absolute minimum required for the patient's care (ECT-nurse, ECT-psychiatrist, anesthesiologist and assistant-anesthesiologist). Appropriate personal protective equipment was used, including a standard ''filtering face piece" 2-respirator, eye protection, a fluid-resistant long-sleeved gown and gloves, as prescribed by the World Health Organization 13 (Fig. 1) . Filtering face piece 2-respirators were worn for a whole treatment day. Gloves were changed according to the 5 WHO indications for hand hygiene. Gowns were changed every treatment day, after a treatment of a COVID-positive patient, or in case of accidental contamination. Glycopyrrolate was used routinely 14 to prevent salivation, thus reducing the risk of producing aerosol. It is suggested that glycopyrrolate also prevents cerebral deoxygenation during ECT. 15 A minor drawback Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait of its use is the fact that patients may experience dry mouth upon recovery. ECT-anesthesia typically involves manual ventilation through a tight mask connected with an open Bain circuit. Manual ventilation is an aerosol-generating procedure, shown to pose an increased risk of coronavirus transmission to healthcare workers. 16 Oxygen-therapy, however, does not increase droplet count. 17 On the other hand, it is suggested that hyperventilation, using a bag-mask, might increase seizure length and improve seizure adequacy. 18 Nevertheless, in our unit, bag-mask-ventilation was avoided and patients were pre-oxygenated using a simple oxygen-mask (5 L/min). Re-organizing ECT-care necessitates a re-allocation of resources. Trained practitioners are needed to perform telephone or video-assessments. Weekly supervision is necessary to assess the need of readmission and rescue ECT. Practitioners and policy makers of nearby regional ECT-units should combine forces to centralize ECT-care and continue treatments in a limited number of centers. Although this approach may cause inconvenience for some patients, it will increase expertise and limit the amount of personnel and resources needed to enable continued access to ECT. In these exceptional times, in which we must all arm ourselves against the coronavirus-pandemic, treating the most vulnerable of our patients is of major importance. Within the limits imposed on us during this pandemic, ECT should be seen as an essential medical procedure and made available in order to prevent long-term mental health consequences in older adults already experiencing serious mental illness. The caveats and measures described here, can guide ECT-practitioners in the context of this viral pandemic. The authors have no disclosures to report.. Mental health-related stigma in health care and mental health-care settings ECT: an essential medical procedure Electroconvulsive therapy in geriatric psychiatry When to consider electroconvulsive therapy (ECT): an expert review with clinical recommendations Relapse following successful electroconvulsive therapy for major depression: a metaanalysis One-year follow-up after discontinuing maintenance electroconvulsive therapy Clinical outcome after discontinuation of maintenance electroconvulsive therapy. A retrospective follow-up study Stress-induced immune dysfunction: implications for health Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study Virtually perfect? Telemedicine for Covid-19 Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention FIGURE 1. ECT-team wearing personal protective equipment, including FFP2-respirator, eye protection shield, fluid-resistant long-sleeved gown and gloves A novel strategy for continuation ECT in geriatric depression: Phase 2 of the PRIDE study World Health Organization P: Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected Comparison of atropine with glycopyrrolate for use in ECT Glycopyrrolate prevents extreme bradycardia and cerebral deoxygenation during electroconvulsive therapy Aerosol-Generating Procedures and Risk of Transmission of Acute Respiratory Infections: A Systematic Review Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections Hyperventilation and electroconvulsive therapy: A literature review